UCB will be at the 2024 AAN Annual Meeting! Join us at booth 1483 to learn more about RYSTIGGO.

US-RZ-2400024

GET UPDATES ABOUT RYSTIGGO

 

Thank you for your interest in RYSTIGGO. Please complete the form below to get important information about this new treatment delivered right to your inbox.

*Indicates required field

*How do you want to hear from us?

(check all that apply)

*Which topics do you want to discuss with a sales professional?
(check all that apply)
*Which topics do you want to discuss with a Rare Reimbursement team member?
(check all that apply)
*Communication preference
*Preferred meeting type
*Specialty
(check all that apply)
What patient gMG subtypes do you treat?
RYSTIGGO is indicated only for AChR-positive and MuSK-positive gMG.
(check all that apply)

I agree that UCB and its business partners may contact me via email regarding UCB treatments, products, and services for informational purposes. I understand that by providing my email address, I am authorized to provide the consent to have emails about the above topics sent to this email address.

At any time, you may unsubscribe from the emailing list, as well as review the Privacy Policy. View full Terms of Use.